These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21237689)

  • 1. [Radiosensitivity of hepatocellular carcinoma].
    Hennequin C; Quero L; Rivera S
    Cancer Radiother; 2011 Feb; 15(1):39-42. PubMed ID: 21237689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
    Salem R; Hunter RD
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for hepatocellular carcinoma: clinicopathological study of seven autopsy cases.
    Aoki K; Okazaki N; Okada S; Nose H; Yoshimori M; Akine Y; Egawa S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1994 Oct; 41(5):427-31. PubMed ID: 7851850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma.
    Furuse J; Ishii H; Nagase M; Kawashima M; Ogino T; Yoshino M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1512-8. PubMed ID: 16174067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation.
    Tai A; Erickson B; Khater KA; Li XA
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):900-7. PubMed ID: 18262101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study on radiotherapy for hepatocellular carcinoma].
    Nagashima T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Sep; 49(9):1141-51. PubMed ID: 2555769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
    Sandroussi C; Dawson LA; Lee M; Guindi M; Fischer S; Ghanekar A; Cattral MS; McGilvray ID; Levy GA; Renner E; Greig PD; Grant DR
    Transpl Int; 2010 Mar; 23(3):299-306. PubMed ID: 19843294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapies for hepatocellular carcinoma.
    Avila MA; Berasain C; Sangro B; Prieto J
    Oncogene; 2006 Jun; 25(27):3866-84. PubMed ID: 16799628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 14. [External radiotherapy for hepatocellular carcinoma].
    Girard N; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):49-53. PubMed ID: 21237691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapolation of normal tissue complication probability for different fractionations in liver irradiation.
    Tai A; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):283-9. PubMed ID: 19289259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of radiation therapy in hepatocellular carcinoma.
    Dawson LA
    Cancer Radiother; 2008 Mar; 12(2):96-101. PubMed ID: 18289910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
    Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
    Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.
    Bal CS; Kumar A
    Trop Gastroenterol; 2008; 29(2):62-70. PubMed ID: 18972764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.